Securities code: Haisco Pharmaceutical Group Co.Ltd(002653) securities abbreviation: Haisco Pharmaceutical Group Co.Ltd(002653) Announcement No.: 2022018 Haisco Pharmaceutical Group Co.Ltd(002653)
Announcement on the reply to the notification letter on the preparations for the meeting of the issuance and Examination Committee of non-public offering of shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Haisco Pharmaceutical Group Co.Ltd(002653) (hereinafter referred to as the “company”) recently received the letter on making preparations for the meeting of the stock issuance and Examination Committee of Haisco Pharmaceutical Group Co.Ltd(002653) non-public development banks (hereinafter referred to as the “notification letter”) issued by the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”).
The company, together with relevant intermediaries, has carefully studied the listed issues and replied one by one according to the requirements of the notification letter. Now, the reply contents are disclosed according to the requirements. For details, please refer to the reply report to the letter on making preparations for the meeting of the issuance and examination committee of Haisco Pharmaceutical Group Co.Ltd(002653) non-public offering of shares issued by cninfo.com, the designated information disclosure media of the company, published on the same day. The company will submit reply materials to the CSRC as required.
The company’s non-public offering of shares still needs to be approved by the CSRC. There is uncertainty about whether it can be approved and the time of final approval. The company will timely perform the obligation of information disclosure in strict accordance with the provisions and requirements of relevant laws and regulations according to the review progress of the matter by the CSRC. Please pay attention to investment risks.
It is hereby announced.
Haisco Pharmaceutical Group Co.Ltd(002653) board of directors April 7, 2022
